Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Verapamil analogues reverse MDR in cancer cells

March 18, 1998

Isis reports incident of data manipulation; clinical progress will not be affected

March 17, 1998

Third phase II trial begins of ONYX-015 in head and neck cancer

March 17, 1998

NaPro's paclitaxel approved in Singapore

March 16, 1998

COX-2 inhibitor displays chemopreventive effects in rats

March 13, 1998

Bristol-Myers Squibb and UT Austin announce cancer collaboration

March 12, 1998

Gemzar approved in Canada

March 12, 1998

R.P. Scherer reveals the identity of two more pipeline products

March 12, 1998

New antitumor and immunosuppressive compounds in development at Klinge

March 12, 1998

Antitumor TEPA analogue described by Lithuanian researchers

March 11, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...